SELNET clinical practice guidelines for bone sarcomaJean‐Yves Blay, Antonio G. Nascimento, Emanuela Palmerini et al.|Critical Reviews in Oncology/Hematology|2022Cited by 32
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trialJavier Martín‐Broto, Virginia Martínez-Marín, Antoîne Italiano et al.|Molecular Cancer|2023Cited by 27
Histopathologic Diagnostic Agreement Study in Bone and Soft Tissue Tumors: The SELNET Sarcoma Network ExperienceAlberto Righi, Angelo Paolo Dei Tos, Marco Gambarotti et al.|JCO Global Oncology|2025Cited by 0